PinPoint Peptides
Back to Research Journal
Research Use Only
Peptide Purity Testing: Why 98%+ Matters for Research

Peptide Purity Testing: Why 98%+ Matters for Research

By PinPoint Research Team·Apr 10, 2026·6 min read

Why Purity Matters

When a peptide is listed at 98% purity, that means 98% of the material is the target compound. The remaining 2% consists of impurities — byproducts of the synthesis process, degradation products, or residual chemicals.

At 98%+, these impurities are minimal and generally do not interfere with experimental results. But at lower purities — say 85% or 90% — up to 15% of the material is something other than what you intended to study. That is not a minor issue. It is a fundamental threat to the validity of your research.

The Real Cost of Low-Purity Peptides

Researchers sometimes choose lower-purity peptides to save money. The per-vial cost is lower, but the hidden costs are substantial:

Non-reproducible results. If your peptide contains 10-15% impurities, those impurities may have biological activity of their own. Your observed effects could be partially or entirely driven by contaminants rather than the target compound. Repeat experiments with a different batch (different impurity profile) may produce different results.

Wasted time. Troubleshooting failed experiments that were actually caused by impure reagents can consume weeks or months of research time. The peptide is often the last variable researchers consider, after re-running protocols, recalibrating instruments, and re-preparing other reagents.

Misleading publications. Research published using inadequately characterized reagents risks contributing inaccurate data to the scientific literature. Peer reviewers increasingly ask for reagent characterization and purity documentation.

How Peptide Purity Is Measured

HPLC (High-Performance Liquid Chromatography)

HPLC is the industry standard for measuring peptide purity. The technique separates components in a sample based on their chemical properties and measures the relative abundance of each.

How it works:

  1. The peptide sample is dissolved and injected into a chromatography column
  2. A mobile phase (solvent mixture) carries the sample through the column
  3. Different compounds interact with the column material at different rates, causing them to separate
  4. A UV detector (typically at 220nm wavelength) measures each component as it exits the column
  5. The detector produces a chromatogram — a graph showing peaks for each separated component

Reading the results:

  • The main peak represents the target peptide
  • Smaller peaks represent impurities
  • Purity percentage = (area of main peak / total area of all peaks) × 100

A clean HPLC result shows one dominant, sharp peak with a flat baseline and minimal additional peaks. This indicates high purity with few detectable impurities.

Mass Spectrometry (MS)

While HPLC tells you how pure a sample is, Mass Spectrometry tells you what it actually is. MS measures the mass-to-charge ratio of molecules, providing a molecular weight that can be compared to the theoretical weight of the target peptide.

Why both tests are needed:

  • HPLC can show 99% purity, but if the main peak is the wrong compound entirely, the purity number is meaningless
  • MS confirms molecular identity — that the 99% pure compound is actually BPC-157 and not a similar-weight contaminant
  • Together, HPLC + MS provide both quantitative purity and qualitative identity confirmation

Common Impurities in Peptide Synthesis

Understanding what impurities look like helps researchers evaluate COA quality and make informed purchasing decisions.

Deletion Peptides

During solid-phase peptide synthesis (SPPS), the amino acid chain is built one residue at a time. If a coupling step fails, the resulting peptide is missing one or more amino acids. These "deletion peptides" are shorter than the target and have a different molecular weight.

Deletion peptides are the most common synthesis impurity. They may retain partial biological activity or exhibit unexpected effects in assays.

Truncated Sequences

If synthesis is terminated prematurely, the result is a truncated peptide — a shorter fragment of the intended sequence. Like deletion peptides, these have different molecular weights and potentially different activity profiles.

Oxidation Products

Peptides containing methionine, cysteine, or tryptophan residues are susceptible to oxidation. Oxidized peptides have slightly higher molecular weights and may exhibit altered biological properties. Proper handling and storage (inert atmosphere, protection from light) minimize oxidation.

Residual TFA Salts

Trifluoroacetic acid (TFA) is commonly used in peptide synthesis and purification. Residual TFA appears as counter-ions associated with basic amino acid residues. While TFA is generally not biologically active at trace levels, its presence reduces the actual peptide content by weight.

A vial containing 5mg of peptide with 80% peptide content contains approximately 4mg of actual peptide and 1mg of TFA salts and moisture. Reputable COAs report peptide content alongside purity.

Residual Solvents

Organic solvents used during synthesis and purification (acetonitrile, DMF, DCM) should be removed during final processing. Residual solvent levels are measured and reported against ICH (International Council for Harmonisation) guidelines to ensure they fall within acceptable limits.

Purity Grades and Their Applications

| Purity Grade | Typical Use | Acceptable For | |-------------|-------------|----------------| | ≥98% | Research grade | Most in vitro and in vivo research applications | | 95–98% | Screening grade | Initial screening, non-quantitative assays | | 90–95% | Crude grade | Antibody production, immunization studies | | Below 90% | Below research grade | Not recommended for most research applications |

For any research intended for publication or requiring reproducible results, 98%+ purity is the minimum standard. Lower grades are only appropriate for preliminary screening where exact quantitation is not required.

How to Evaluate a Vendor's Purity Claims

Ask for batch-specific data

Generic purity claims ("our peptides are >99% pure") without supporting documentation are marketing, not science. Request or verify the COA for the specific batch/lot of your product.

Check the chromatogram

A purity percentage without the underlying HPLC chromatogram cannot be independently evaluated. The chromatogram shows you the raw data — the actual peaks, their relative sizes, and the baseline quality.

Verify molecular identity

A COA with only HPLC data and no Mass Spectrometry result leaves molecular identity unconfirmed. Both tests are necessary for a complete quality assessment.

Compare across batches

If you order the same peptide multiple times, compare the COAs. Purity values should be consistently high (>98%) but not suspiciously identical. Real analytical data shows natural batch-to-batch variation (e.g., 98.3%, 99.1%, 98.7%).

PinPoint's Approach to Purity

At PinPoint Peptides, we maintain a 98%+ purity standard across our entire catalog. Every batch undergoes HPLC purity analysis and Mass Spectrometry identity confirmation through third-party testing. Results are published directly on each product page — no email requests, no support tickets.

We believe that quality documentation should be the starting point of the purchasing decision, not an afterthought. If you cannot verify what you are buying, you cannot trust what you are researching.

All products sold by PinPoint Peptides are strictly for laboratory and research purposes only. Not for human consumption.

Related Resources

Written by

PinPoint Research Team

Research editors — PinPoint Peptides, Canada

The PinPoint Research Team is a collective of Canadian contributors focused on translating peer-reviewed peptide science into clear, accurate reference material for the research community. Every article is written with direct reference to primary literature, cross-checked against batch Certificates of Analysis, and reviewed for compliance with Canadian regulatory standards before publication.